Comparison of public and private payments for direct-acting antivirals (DAAs) across Canada

Can Liver J. 2021 Nov 11;4(4):426-429. doi: 10.3138/canlivj-2020-0041. eCollection 2021 Fall.
No abstract available

Keywords: Canada; antiviral; health policy; hepatitis C; prescription drugs.

Grant support

This study was funded by the Canadian Institutes of Health Research (CIHR) and the Health System Research Fund (HSRF) from the Ontario Ministry of Health.